Jazz Pharmaceuticals Public Limited Company (JAZZ)
-NasdaqGS 90.74 
0.36(0.40%) 10:42AM EDT - Nasdaq Real Time Price
| Prev Close: | 91.10 |
|---|
| Open: | 90.69 |
|---|
| Bid: | 90.61 x 100 |
|---|
| Ask: | 90.69 x 300 |
|---|
| 1y Target Est: | 92.65 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 90.13 - 91.38 |
|---|
| 52wk Range: | 47.37 - 93.84 |
|---|
| Volume: | 126,376 |
|---|
| Avg Vol (3m): | 672,630 |
|---|
| Market Cap: | 5.28B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Synageva Raises FundsZacks(Tue, Oct 1)
- Interesting JAZZ Put And Call For November 16that Forbes(Tue, Oct 1)
- Cempra (CEMP) Worth a Look: Stock Up 6.1%Zacks(Tue, Oct 1)
- Important Upcoming Catalyst For Antares - FDA Decision Expected October 14at Seeking Alpha(Tue, Oct 1)
- Zacks Investment Ideas feature highlights: FleetCor Technologies, Jazz Pharmaceuticals and Pioneer Southwest Energy PartnersZacks(Tue, Oct 1)
- Update on Ariad StudyZacks(Mon, Sep 30)
- Stocks Suffer Losses In Rising Volumeat Investor's Business Daily(Mon, Sep 30)
- Stocks Down In Weak Trade; RealPage Trips Sell Ruleat Investor's Business Daily(Mon, Sep 30)
- Stocks Recover Off Lows; Chipotle Surges On Analyst Noteat Investor's Business Daily(Mon, Sep 30)
- IBD 50 Up For Week, But Not By Muchat Investor's Business Daily(Fri, Sep 27)
- Jazz Pharmaceuticals Stares At Generic Threat, Thrivesat Investor's Business Daily(Fri, Sep 27)
- XenoPort and Patheon Ink DealZacks(Fri, Sep 27)
- Santarus (SNTS) in Focus: Stock Advances 6.2%Zacks(Fri, Sep 27)
- Agenus Raises FundsZacks(Thu, Sep 26)
- Update on Amarin StudyZacks(Thu, Sep 26)
Key Statistics
| Forward P/E (1 yr): | 11.49 |
|---|
| P/S (ttm): | 6.94 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 6.31 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 1.69 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | 0.69 |
|---|
Business Summary
Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other coun...
View More